KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
Please contact us if you have any questions about Indirect Tax or on any other matter.
Jean Ngan Li
Co-Leader, Indirect Taxes, Asia Pacific
+86 (755) 2547 1198
Lachlan Wolfers
Leader, Centre of Excellence for Indirect Taxes, China
+86 (21) 2212 3515
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.
Submit an enquiry about our services, industry practices, or get in touch with one of our professionals.